Global Virus Like Particles Market

Global Virus Like Particles Market Research Report 2021

Global Virus Like Particles Market

Global Virus Like Particles Market Research Report 2021


Insights into the Virus Like Particles Market include supply chain optimization, Virus Like Particles challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Virus Like Particles Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Virus Like Particles Market Overview:

Global Virus Like Particles Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Virus Like Particles involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Virus Like Particles Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Virus Like Particles market in 2020.

Global Virus Like Particles Market Segmentation

By Type, Virus Like Particles market has been segmented into:

Adeno-Associated Virus

HIV

Hepatitis B Virus

Hepatitis C Virus

Others

By Application, Virus Like Particles market has been segmented into:

Vaccines

Mycoviruses

Virus Research

Therapeutic and Imaging Agents

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Virus Like Particles market are:

GlaxoSmithKline

Merck

Novavax

Takeda

Medicago

MedImmune

TechnoVax

Agilvax

Allergy Therapeutics

Serum Institute of India

GeoVax Labs

Cytos Biotechnology

ANGANY Genetics

CPL Biologicals

Xiamen Innovax Biotech

1. Market Overview of Virus Like Particles

1.1 Virus Like Particles Market Overview

1.1.1 Virus Like Particles Product Scope

1.1.2 Market Status and Outlook

1.2 Virus Like Particles Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Virus Like Particles Historic Market Size by Regions (2015-2020)

1.4 Virus Like Particles Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Virus Like Particles Sales Market by Type (2015-2026)

2.1 Global Virus Like Particles Historic Market Size by Type (2015-2020)

2.2 Global Virus Like Particles Forecasted Market Size by Type (2021-2026)

2.3 Adeno-Associated Virus

2.4 HIV

2.5 Hepatitis B Virus

2.6 Hepatitis C Virus

2.7 Others

3. Covid-19 Impact Virus Like Particles Sales Market by Application (2015-2026)

3.1 Global Virus Like Particles Historic Market Size by Application (2015-2020)

3.2 Global Virus Like Particles Forecasted Market Size by Application (2021-2026)

3.3 Vaccines

3.4 Mycoviruses

3.5 Virus Research

3.6 Therapeutic and Imaging Agents

3.7 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Virus Like Particles Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Virus Like Particles Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Virus Like Particles Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Virus Like Particles Business

5.1 GlaxoSmithKline

5.1.1 GlaxoSmithKline Company Profile

5.1.2 GlaxoSmithKline Virus Like Particles Product Specification

5.1.3 GlaxoSmithKline Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Merck

5.2.1 Merck Company Profile

5.2.2 Merck Virus Like Particles Product Specification

5.2.3 Merck Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Novavax

5.3.1 Novavax Company Profile

5.3.2 Novavax Virus Like Particles Product Specification

5.3.3 Novavax Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Takeda

5.4.1 Takeda Company Profile

5.4.2 Takeda Virus Like Particles Product Specification

5.4.3 Takeda Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Medicago

5.5.1 Medicago Company Profile

5.5.2 Medicago Virus Like Particles Product Specification

5.5.3 Medicago Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 MedImmune

5.6.1 MedImmune Company Profile

5.6.2 MedImmune Virus Like Particles Product Specification

5.6.3 MedImmune Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 TechnoVax

5.7.1 TechnoVax Company Profile

5.7.2 TechnoVax Virus Like Particles Product Specification

5.7.3 TechnoVax Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Agilvax

5.8.1 Agilvax Company Profile

5.8.2 Agilvax Virus Like Particles Product Specification

5.8.3 Agilvax Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Allergy Therapeutics

5.9.1 Allergy Therapeutics Company Profile

5.9.2 Allergy Therapeutics Virus Like Particles Product Specification

5.9.3 Allergy Therapeutics Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Serum Institute of India

5.10.1 Serum Institute of India Company Profile

5.10.2 Serum Institute of India Virus Like Particles Product Specification

5.10.3 Serum Institute of India Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 GeoVax Labs

5.11.1 GeoVax Labs Company Profile

5.11.2 GeoVax Labs Virus Like Particles Product Specification

5.11.3 GeoVax Labs Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Cytos Biotechnology

5.12.1 Cytos Biotechnology Company Profile

5.12.2 Cytos Biotechnology Virus Like Particles Product Specification

5.12.3 Cytos Biotechnology Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 ANGANY Genetics

5.13.1 ANGANY Genetics Company Profile

5.13.2 ANGANY Genetics Virus Like Particles Product Specification

5.13.3 ANGANY Genetics Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 CPL Biologicals

5.14.1 CPL Biologicals Company Profile

5.14.2 CPL Biologicals Virus Like Particles Product Specification

5.14.3 CPL Biologicals Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.15 Xiamen Innovax Biotech

5.15.1 Xiamen Innovax Biotech Company Profile

5.15.2 Xiamen Innovax Biotech Virus Like Particles Product Specification

5.15.3 Xiamen Innovax Biotech Virus Like Particles Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Virus Like Particles Market Size (2015-2026)

6.2 North America Virus Like Particles Key Players in North America (2015-2020)

6.3 North America Virus Like Particles Market Size by Type (2015-2020)

6.4 North America Virus Like Particles Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Virus Like Particles Market Size (2015-2026)

7.2 East Asia Virus Like Particles Key Players in North America (2015-2020)

7.3 East Asia Virus Like Particles Market Size by Type (2015-2020)

7.4 East Asia Virus Like Particles Market Size by Application (2015-2020)

8. Europe

8.1 Europe Virus Like Particles Market Size (2015-2026)

8.2 Europe Virus Like Particles Key Players in North America (2015-2020)

8.3 Europe Virus Like Particles Market Size by Type (2015-2020)

8.4 Europe Virus Like Particles Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Virus Like Particles Market Size (2015-2026)

9.2 South Asia Virus Like Particles Key Players in North America (2015-2020)

9.3 South Asia Virus Like Particles Market Size by Type (2015-2020)

9.4 South Asia Virus Like Particles Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Virus Like Particles Market Size (2015-2026)

10.2 Southeast Asia Virus Like Particles Key Players in North America (2015-2020)

10.3 Southeast Asia Virus Like Particles Market Size by Type (2015-2020)

10.4 Southeast Asia Virus Like Particles Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Virus Like Particles Market Size (2015-2026)

11.2 Middle East Virus Like Particles Key Players in North America (2015-2020)

11.3 Middle East Virus Like Particles Market Size by Type (2015-2020)

11.4 Middle East Virus Like Particles Market Size by Application (2015-2020)

12. Africa

12.1 Africa Virus Like Particles Market Size (2015-2026)

12.2 Africa Virus Like Particles Key Players in North America (2015-2020)

12.3 Africa Virus Like Particles Market Size by Type (2015-2020)

12.4 Africa Virus Like Particles Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Virus Like Particles Market Size (2015-2026)

13.2 Oceania Virus Like Particles Key Players in North America (2015-2020)

13.3 Oceania Virus Like Particles Market Size by Type (2015-2020)

13.4 Oceania Virus Like Particles Market Size by Application (2015-2020)

14. South America

14.1 South America Virus Like Particles Market Size (2015-2026)

14.2 South America Virus Like Particles Key Players in North America (2015-2020)

14.3 South America Virus Like Particles Market Size by Type (2015-2020)

14.4 South America Virus Like Particles Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Virus Like Particles Market Size (2015-2026)

15.2 Rest of the World Virus Like Particles Key Players in North America (2015-2020)

15.3 Rest of the World Virus Like Particles Market Size by Type (2015-2020)

15.4 Rest of the World Virus Like Particles Market Size by Application (2015-2020)

16 Virus Like Particles Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Virus Like Particles Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Virus Like Particles Market?
Some of the finest and top-notch companies pioneering the Virus Like Particles Market are GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, TechnoVax, Agilvax, Allergy Therapeutics, Serum Institute of India, GeoVax Labs, Cytos Biotechnology, ANGANY Genetics, CPL Biologicals, Xiamen Innovax Biotech.
How is the competition changing gears in the Virus Like Particles Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as GlaxoSmithKline, Merck, Novavax, Takeda, Medicago, MedImmune, TechnoVax, Agilvax, Allergy Therapeutics, Serum Institute of India, GeoVax Labs, Cytos Biotechnology, ANGANY Genetics, CPL Biologicals, Xiamen Innovax Biotech will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
What are the major applications of the Virus Like Particles Market?
Depending upon the type of applications, the Virus Like Particles Market has been segmented into and other applications.
What is the expected rate of growth in the Virus Like Particles Market?
From 2025 to 2030, the Virus Like Particles Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What does the future hold for the Virus Like Particles Market?
As the shift to value addition continues, companies in the Virus Like Particles Market face the dual challenge of improving interoperability to optimize performance and experience.
What are the top priorities for the growth of the Virus Like Particles Market?
In this highly competitive and rapidly evolving Virus Like Particles Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.